Head to head
Dentsply Sirona vs Intuitive Surgical
Side-by-side on the measures that matter, with a plain-English read. Full detail: XRAY · ISRG
XRAY
Dentsply Sirona
8.54+0.23%
1-year price shape — -30% over the period
Quant Rating E · 11/100
vs
ISRG
Intuitive Surgical
414.52+2.41%
1-year price shape — -6% over the period
Quant Rating D · 30/100
1-year performance, rebased to 100
Intuitive Surgical edges it on the scoreable measures. Intuitive Surgical has the highest Quant Rating (30); Intuitive Surgical has done best over the past year (-6%); Intuitive Surgical earns the most per share.
| XRAY | ISRG | |
|---|---|---|
| Snapshot | ||
| Sector | Medical Instruments & Supplies | Medical Instruments & Supplies |
| Last price | 8.54 | 414.52 |
| Change today | +0.23% | +2.41% |
| 1-year return | -29.7% | -6.0% |
| Market cap | $1.70B | $146.44B |
| 52-week range | 8.38 – 14.76 | 328.57 – 603.88 |
| Valuation | ||
| P/E (TTM) | -3.13 | 47.54 |
| P/E percentile, own 5-yr range | 65th | 6th |
| P/B | 1.26 | 8.06 |
| Dividend yield | 3.75% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | -3.00 | 7.87 |
| Net profit (TTM) | $-598.06M | $2.78B |
| Revenue (TTM) | $3.64B | $11.03B |
| Revenue growth (YoY) | -4.1% | +18.5% |
| Gross margin | 49.5% | 66.7% |
| Operating margin | 5.1% | 31.3% |
| Net margin | -15.0% | 28.4% |
| Free cash flow (TTM) | $143.00M | $3.22B |
| Ownership & sentiment | ||
| Institutional ownership | 115.9% | 88.8% |
| Insider activity (12mo) | 39 buy / 7 sell | 21 buy / 29 sell |
| Short interest (% of float) | 12.3% | 2.3% |
| Analyst consensus | 9% buy / 82% hold / 9% sell (11) | 86% buy / 14% hold (21) |
| Analyst price target | $13 (+51%) | $490 (+18%) |
| StockVane view | ||
| StockVane Quant Rating | E (11) | D (30) |
| Company | ||
| Employees | 14,000 | 17,021 |
| Founded | 1899 | 1995 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.